Silicon Laboratories Reports Q4 2025 Earnings: Revenue Up 25% YoY, EPS Beats Estimates Amid Texas Instruments Acquisition

SLAB
February 04, 2026

Silicon Laboratories Inc. reported fourth‑quarter 2025 results with revenue of $208.2 million, a 25% year‑over‑year increase from $166.25 million in Q4 2024. Adjusted earnings per share were $0.56, beating the consensus estimate of $0.54 by $0.02, or 3.7%. The quarter’s earnings beat reflects disciplined cost management and a favorable product mix that offset the $0.11 per share loss reported in Q4 2024.

Revenue growth was driven by strong demand for the company’s Series 2 and Series 3 wireless platforms. Industrial & Commercial revenue rose to $122 million, while Home & Life revenue reached $87 million, reflecting continued expansion in industrial IoT and home‑automation markets. The higher mix of high‑margin industrial products contributed to the 63.6% adjusted gross margin, an improvement over the 58.0% margin reported in Q3 2025.

The company’s earnings release coincided with the announcement that Texas Instruments will acquire Silicon Laboratories for $231 per share in cash, valuing the deal at approximately $7.5 billion. The acquisition, pending regulatory and shareholder approval, prompted Silicon Laboratories to suspend forward‑looking guidance and cancel its earnings call scheduled for February 10. Management emphasized that the deal will provide significant synergies and strengthen TI’s embedded processing strategy.

President and CEO Matt Johnson noted that “the Silicon Labs team completed fiscal 2025 with continued strong execution, delivering an impressive year‑over‑year revenue growth of 34% for the full year, and that momentum continues as we enter 2026 with record opportunity funnel and design‑win traction.” He added that the acquisition will accelerate growth and broaden the company’s product portfolio.

Investors reacted negatively to the guidance suspension and acquisition announcement, reflecting concerns about the impact on future earnings forecasts and the timing of the deal’s completion. The market’s focus on the acquisition premium and regulatory uncertainty outweighed the positive earnings beat.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.